Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Savolitinib phase II study in MET-amplified advanced gastric or gastroesophageal junction adenocarcinoma
CTR20211156Phase 2Completed
- Sponsor
- HUTCHMED
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of savolitinib, sponsored by HUTCHMED. Started Jul 2021; status: completed.
02
Drugs
savolitinib
Beyond the preview
Go deeper on CTR20211156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211156.